Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.

Publikation

Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.

Wissenschaftlicher Artikel/Review - 24.06.2024

Moschouri Eleni, Salemme Gloria, Baserga Adriana, Cerny Andreas, Deibel Ansgar, Muellhaupt Beat, Meier Marie-Anne, Bernsmeier Christine, Ongaro Marie, Negro Francesco, Grosjean Marielle, Clerc Olivier F, Künzler-Heule Patrizia, Semela David, Hobi Gabriel, Stickel Felix, Mathieu Adeline, Mdawar-Bailly Elise, Faouzi Mohamed, Moradpour Darius, Fraga Montserrat

Zitation

Moschouri E, Salemme G, Baserga A, Cerny A, Deibel A, Muellhaupt B, Meier M, Bernsmeier C, Ongaro M, Negro F, Grosjean M, Clerc O, Künzler-Heule P, Semela D, Hobi G, Stickel F, Mathieu A, Mdawar-Bailly E, Faouzi M, Moradpour D, Fraga M. Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis. Swiss Med Wkly 2024; 154:3698.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Swiss Med Wkly 2024; 154

Veröffentlichungsdatum

24.06.2024

eISSN (Online)

1424-3997

Seiten

3698

Kurzbeschreibung/Zielsetzung

Direct-acting antivirals (DAAs) have revolutionised the management of chronic hepatitis C. We analysed the use of different generations of DAAs over time in Switzerland and investigated factors predictive of treatment failure.